The EPAD Longitudinal Cohort Study has recruited its 1,000thparticipant at the University of Oxford (UK) this 21st September on World Alzheimer’s Day.
EPAD is one of the world leading dementia prevention studies, led from the University of Edinburgh. It is a Europe-wide collaboration aiming to improve the understanding of the early stages of Alzheimer’s disease. The EPAD project offers a unique platform for testing and developing preventative treatments for Alzheimer’s dementia.
EPAD is set up to recruit from existing cohort studies as well as clinics across Europe. EPAD has established the first pan-European register including more than 30,000 research participants aged 50 or over across the dementia risk spectrum. From this register, individuals who do not have dementia are invited to join the EPAD Cohort study, Many participants in the EPAD Cohort study may be invited to participate in the EPAD Proof of Concept Trial to test new treatments for the prevention of Alzheimer’s dementia.
Participants in the EPAD Cohort are contributing to the advancement of science around dementia prevention in 20 locations across 7 European countries (i.e. France, Italy, the Netherlands, Spain, Switzerland, Sweden and UK)
More about EPAD at http://ep-ad.org/.